1-7 of 7
Fangping Chen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Altered Iron Metabolism Is a New Targetable Hallmark for Multiple Myeloma

Can Li, MD, Xuelian Tan, Qierra Brockman, BA, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Marta Chesi, PhD, P. Leif Bergsagel, MD, Fangping Chen, MD PhD, Ivana Frech, DSc, PhD MBA, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3059.
https://doi.org/10.1182/blood-2019-123473
Published: 2019
Journal Articles

TRIP13 Modulates Protein Deubiquitination to Promote Myeloma Progression

Can Li, MD, Reinaldo Franqui-Machin, Jiliang Xia, PhD, Gregory S. Thomas, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Fangping Chen, MD PhD, Ivana Frech, DSc, PhD MBA, Guido J. Tricot, MD PhD, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 854.
https://doi.org/10.1182/blood-2019-123818
Published: 2019
Journal Articles

NKG2D Negatively Regulates CD4 T Cells in Allo-Response in Mice

Mengmeng Zhang, MD, Yongxia Wu, PhD MD, David Bastian, Hung D Nguyen, PhD, Supinya Iamsawat, MSc, Anusara Daenthanasanmak, Fangping Chen, MD PhD, Xue-Zhong Yu, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2279.
https://doi.org/10.1182/blood.V130.Suppl_1.2279.2279
Published: 2017
Journal Articles

Post-Transplantation Cyclophosphamide and Short-Term Methotrexate for Tolerance Induction in HLA-Haploidentical Transplantation for Severe Aplastic Anemia

Bin Fu, MD, Yajing Xu, MD PhD, Yan Chen, MD PhD, Fangping Chen, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3237.
https://doi.org/10.1182/blood.V130.Suppl_1.3237.3237
Published: 2017
Journal Articles

Long-Term Use of Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Chinese Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): MM-024 Expanded Access Program (EAP)

Xin Du, MD, Jie Jin, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiaoyan Ke, MD PhD, Xiao Li, MD PhD, Depei Wu, MD, Fanyi Meng, MD, Dena DeMarco, Jingshan Zhang, PhD, Jay Mei, MD, Jian Hou, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5737.
https://doi.org/10.1182/blood.V124.21.5737.5737
Published: 2014
Journal Articles

The MM-021 Trial Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma: Impact Of Prior Therapies On Efficacy and Safety

Jie Jin, MD, Xin Du, MD, Zhen Cai, MD, Fangping Chen, MD, Dao-bin Zhou, MD, Li Yu, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jianmin Wang, MD, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jian Hou, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3227.
https://doi.org/10.1182/blood.V122.21.3227.3227
Published: 2013
Journal Articles

Efficacy and Safety Of Lenalidomide Plus Low-Dose Dexamethasone In Chinese Patients With Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment: MM-021 Subgroup Analysis

Dao-bin Zhou, MD, Li Yu, MD, Xin Du, MD, Jie Jin, MD, Zhen Cai, MD, Fangping Chen, MD, Xiao Li, MD, PhD, Depei Wu, MD, Fanyi Meng, MD, Huisheng Ai, MMed, Jingshan Zhang, PhD, Honeylet Wortman-Vayn, Jay Mei, MD, Jianmin Wang, MD, Jian Hou, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5374.
https://doi.org/10.1182/blood.V122.21.5374.5374
Published: 2013